Weaning of inhaled nitric oxide: is there a best strategy?

Background: Inhaled nitric oxide (iNO) has been used in the treatment of pulmonary hypertension in neonates for many years. iNO was approved by the FDA in 1999 for hypoxic respiratory failure (HRF) in term and near term infants, defined as > 34 weeks gestational age (GA). iNO is used for persiste...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Anita M. Ware (Author), Sergio G. Golombek (Author)
Formato: Livro
Publicado em: Hygeia Press di Corridori Marinella, 2015-04-01T00:00:00Z.
Assuntos:
Acesso em linha:Connect to this object online.
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Internet

Connect to this object online.

3rd Floor Main Library

Detalhes do Exemplar 3rd Floor Main Library
Área/Cota: A1234.567
Cód. Barras: 1 Disponível